Market Overview:
The global Liquid Biopsy Marketwas valued at USD 576.43 million in 2016 and is projected to reach USD 3747.18million by 2025, growing at a CAGR of 23.12% from 2017 to 2025.
Liquid biopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood or for pieces of DNA from tumor cells that are in the blood. A liquid biopsy may be used to help find cancer at an early stage. With increasing ratio of Cancer patients all over the Globe, Specially breast and prostate cancer, the need of more efficient technologies like liquid biopsy is being taken up by major players, for better and early diagnosis.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing cases of cancer
1.2 Growing demand for non-invasive procedures
1.3 Growing support of government and health organizations
1.4 Technological development at par with market revenues
1.5 Growing awareness and demand of personalized medicine
1.6 Fund availability
2. Market Restraints
2.1 Low sensitivity
Market Segmentation:
1. Global Liquid Biopsy Market, by Circulating Biomarker:
1.1 Circulating Tumor Cells
1.2 Circulating Tumor DNA (CTDNA)
1.3 Cell-Free DNA
1.4 Extracellular Vesicles (Evs)
1.5 Other Circulating Biomarkers
2. Global Liquid Biopsy Market, by Product and Service:
2.1 Assay Kits
2.2 Instruments
2.3 Services
3. Global Liquid Biopsy Market, by End User:
3.1 Reference Laboratories
3.2 Hospitals and Physician Laboratories
3.3 Academic and Research Centers
3.4 Other End Users
4. Global Liquid Biopsy Market, by Application:
4.1 Cancer Applications
4.1.1 Lung Cancer
4.1.2 Breast Cancer
4.1.3 Colorectal Cancer
4.1.4 Prostate Cancer
4.1.5 Liver Cancer
4.1.6 Other Cancers
4.2 Non-Cancer Applications
5. Global Liquid Biopsy Market, by Clinical application:
5.1 Early Cancer Screening
5.2 Therapy Selection
5.3 Treatment Monitoring
5.4 Recurrence Monitoring
6. Global Liquid Biopsy Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Biocept, Inc.
2. Qiagen N.V.
3. Roche Diagnostics
4. Bio-Rad Laboratories, Inc.
5. Myriad Genetics, Inc
6. Menarini-Silicon Biosystems
7. Trovagene, Inc.
8. Guardant Health, Inc.
9. Mdxhealth SA
10. Genomic Health, Inc.
11. Raindance Technologies, Inc
12. Thermo Fisher Scientific Inc.
13. Illumina, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Liquid Biopsy Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL LIQUID BIOPSY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL LIQUID BIOPSY MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER
5.1 Overview
5.2 Circulating Tumor Cells
5.3 Circulating Tumor DNA (CTDNA)
5.4 Cell-Free DNA
5.5 Extracellular Vesicles (Evs)
5.6 Others
6 GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT AND SERVICE
6.1 Overview
6.2 Assay Kits
6.3 Instruments
6.4 Services
7 GLOBAL LIQUID BIOPSY MARKET, BY END USER
7.1 Overview
7.2 Reference Laboratories
7.3 Hospitals and Physician Laboratories
7.4 Academic and Research Centers
7.5 Other End Users
8 GLOBAL LIQUID BIOPSY MARKET, BY APPLICATION
8.1 Overview
8.2 Cancer Applications
8.2.1 Lung Cancer
8.2.2 Breast Cancer
8.2.3 Colorectal Cancer
8.2.4 Prostate Cancer
8.2.5 Liver Cancer
8.2.6 Other Cancers
8.3 Non-Cancer Applications
9 GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION
9.1 Overview
9.2 Early Cancer Screening
9.3 Therapy Selection
9.4 Treatment Monitoring
9.5 Recurrence Monitoring
10 GLOBAL LIQUID BIOPSY MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 â€" 2025
11 GLOBAL LIQUID BIOPSY MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Biocept, Inc.
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Qiagen N.V.
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Roche Diagnostics
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Bio-Rad Laboratories, Inc.
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Myriad Genetics, Inc
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Menarini-Silicon Biosystems
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 Trovagene, Inc.
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Guardant Health, Inc.
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 Mdxhealth SA
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments
12.10 Genomic Health, Inc.
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments
12.11 Raindance Technologies, Inc
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments
12.12 Thermo Fisher Scientific Inc.
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments
12.13 Illumina, Inc.
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments
13 Appendix
13.1 Related Reports
The Liquid Assisted Air Cooling Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Liquid Chemical Shipping Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactur...
The Precision Liquid Cooling Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
Market Overview
The Asia Pacific Sustainable Aviation Fuel Market is positioned for substantial growth from 2024 to 2034, driven by escalating environmental regulations, increasing corporate sustainability initiatives, and a growing emphasis on reducing aviation carbon emissions. The ma...
Market Overview
The Europe Sustainable Aviation Fuel Market is poised for significant growth from 2024 to 2034, driven by escalating environmental concerns and regulatory pressures to reduce carbon emissions in the aviation sector. The market is projected to reach USD XX.XX billion by 2...
Market Overview
The North America Sustainable Aviation Fuel Market is projected to experience robust growth from 2024 to 2034, driven by increasing environmental regulations, rising focus on reducing carbon emissions in aviation, and advancements in alternative fuel technologies. By 203...
Market Overview
The Global Sustainable Aviation Fuel Market is poised for substantial growth over the forecast period, driven by increasing environmental regulations, rising awareness of carbon emissions, and the aviation industry's commitment to reducing its carbon footprint. Valued at...
The Liquid Organic Hydrogen Carrier System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Liquid Organic Hydrogen Carriers Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Liquid Organic Hydrogen Carrier (LOHC) Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competit...